UNSPSC 51283956: Sulfathiazole sodium monohydrate

This classification denotes a sulfonamide anti-infective agent with the molecular formula C9H8N3O2S2.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W6NDW4K12P, chemically known as benzenesulfonamide, 4-amino-n-2-thiazolyl-, sodium salt, hydrate (1:1:1), but more generally known as sulfathiazole sodium monohydrate, which bears US NIH Compound Identifier 24975.

European Medicines Agency schedules sulfathiazole sodium monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10731MIG. Most nations, for tariff purposes, schedule sulfathiazole sodium monohydrate under HS 29350090. SMILES: C1CC(CCC1N)S(=O)(=O)[N-]C2NCCS2.O.[NA+].

UNSPSC 51283956 Sulfathiazole sodium monohydrate is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities tagged under this code in recent months involve pharmaceutical products—Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through an Illinois Department of Public Health piggyback contract, and Naloxone and drug deactivation systems through Seminole County, Florida—none of which are sulfathiazole sodium monohydrate. State and local purchasing offices appear to use this code inconsistently or as a catch-all for pharmaceutical procurement, despite the code's specificity to a single active pharmaceutical ingredient. The issuing bodies in the recent record are a state health department and a county government, both sourcing through standing pharmaceutical supply contracts or competitive bidding.

Geographic activity appears limited to Illinois and Florida in the recent record, with no additional opportunities supporting a broader regional characterization. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC (Bid 26-482DPH-PREPD-B-53392, completed August 28, 2026, $2,999,999.11 over the contract term including renewals) for Doxycycline Hyclate and Ciprofloxacin Hydrochloride under an Invitation for Bid process. Seminole County, Florida issued an IFB (60459723LAS, posted June 30, 2026, response deadline July 26, 2023) to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually. Neither opportunity represents procurement of sulfathiazole sodium monohydrate itself, suggesting the code does not currently reflect active state and local buying patterns for this specific product.